Elevated Circulating TWEAK Levels in Systemic Sclerosis: Association with Lower Frequency of Pulmonary Fibrosis

被引:25
作者
Yanaba, Koichi [1 ]
Yoshizaki, Ayumi [1 ]
Muroi, Eiji [1 ]
Hara, Toshihide [1 ]
Ogawa, Fumihide [1 ]
Usui, Aya [1 ]
Hasegawa, Minoru [2 ]
Fujimoto, Manabu [2 ]
Takehara, Kazuhiko [2 ]
Sato, Shinichi [1 ]
机构
[1] Nagasaki Univ, Dept Dermatol, Grad Sch Biomed Sci, Nagasaki 8528501, Japan
[2] Kanazawa Univ, Dept Dermatol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
关键词
SYSTEMIC SCLEROSIS; ELISA; CYTOKINE; PULMONARY FIBROSIS; TUMOR NECROSIS FACTOR-RELATED WEAK INDUCER OF APOPTOSIS; SERUM-LEVELS; PATHOGENESIS; CLASSIFICATION; CHEMOKINES; RANTES; SKIN; ANTIBODIES; CYTOKINE; RECEPTOR; SUBSETS;
D O I
10.3899/jrheum.081310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine serum levels of tumor necrosis factor-related weak inducer of apoptosis (TWEAK) and its clinical associations in patients with systemic sclerosis (SSc). Methods. Serum TWEAK levels from 70 patients with SSc were examined by ELISA. In a retrospective longitudinal study, sera from 23 patients with SSc were analyzed (followup 0.8-7.2 yrs). Results. Serum TWEAK levels were elevated in patients with SSc (n = 70) compared with healthy controls (n = 3 1) and patients with systemic lupus erythematosus (n = 22). Among patients with SSc, there were no differences in serum TWEAK levels between limited cutaneous SSc and diffuse cutaneous SSc. Patients with SSc who had elevated TWEAK levels less often had pulmonary fibrosis and decreased vital capacity than those with normal TWEAK levels. In the longitudinal study, SSc patients with inactive pulmonary fibrosis or without pulmonary fibrosis consistently exhibited increased TWEAK levels, while those with active pulmonary fibrosis showed decreased TWEAK levels during the followup period. Conclusion. TWEAK levels were increased in patients with SSc, and associated with a lower frequency of pulmonary fibrosis in patients with SSc. TWEAK could be a protective factor against the development of pulmonary fibrosis in this disease and as such would be a possible therapeutic target. (First Release June 15 2009; J Rheumatol 2009;36:1657-62; doi: 10.3899/jrheum.081310)
引用
收藏
页码:1657 / 1662
页数:6
相关论文
共 33 条
[1]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]   RANTES: a versatile and controversial chemokine [J].
Appay, V ;
Rowland-Jones, SL .
TRENDS IN IMMUNOLOGY, 2001, 22 (02) :83-87
[3]   Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis [J].
Bolster, MB ;
Ludwicka, A ;
Sutherland, SE ;
Strange, C ;
Silver, RM .
ARTHRITIS AND RHEUMATISM, 1997, 40 (04) :743-751
[4]   Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome [J].
Bouros, D ;
Wells, AU ;
Nicholson, AG ;
Colby, TV ;
Polychronopoulos, V ;
Pantelidis, P ;
Haslam, PL ;
Vassilakis, DA ;
Black, CM ;
du Bois, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (12) :1581-1586
[5]   The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity [J].
Campbell, S ;
Michaelson, J ;
Burkly, L ;
Putterman, C .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :2273-2284
[6]   TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis [J].
Chicheportiche, Y ;
Bourdon, PR ;
Xu, HD ;
Hsu, YM ;
Scott, H ;
Hession, C ;
Garcia, I ;
Browning, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32401-32410
[7]   Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies [J].
Chicheportiche, Y ;
Chicheportiche, R ;
Sizing, I ;
Thompson, J ;
Benjamin, CB ;
Ambrose, C ;
Dayer, JM .
ARTHRITIS RESEARCH, 2002, 4 (02) :126-133
[8]  
CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892
[9]   Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis [J].
Desplat-Jégo, S ;
Creidy, R ;
Varriale, S ;
Allaire, N ;
Luo, Y ;
Bernard, D ;
Hahm, K ;
Burkly, L ;
Boucraut, J .
CLINICAL IMMUNOLOGY, 2005, 117 (01) :15-23
[10]   Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis [J].
Distler, O ;
Rinkes, B ;
Hohenleutner, U ;
Schölmerich, J ;
Landthaler, M ;
Lang, B ;
Gay, S ;
Müller-Ladner, U .
RHEUMATOLOGY INTERNATIONAL, 1999, 19 (1-2) :39-46